Effects of CCR2 and CCR5 polymorphisms on HIV-1 infection in Thai females

Journal of Acquired Immune Deficiency Syndromes

Volumn 47, Issue 3, 2008, Pages 293-297

  Wichukchinda, Nuanjun ^a   Nakayama, Emi E ^b   Rojanawiwat, Archawin ^a   Pathipvanich, Panita ^c   Auwanit, Wattana ^a   Vongsheree, Suthon ^a   Ariyoshi, Koya ^d   Sawanpanyalert, Pathom ^a   Shioda, Tatsuo ^b  

^a MINISTRY OF PUBLIC HEALTH   (Thailand)

^b OSAKA UNIVERSITY   (Japan)

^c LAMPANG HOSPITAL   (Thailand)

^d NAGASAKI UNIVERSITY   (Japan)

Author keywords

CCR2; CCR5; HIV 1 infection; SNPs; Thai

Indexed keywords

CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR5; CCR2 PROTEIN, HUMAN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE TRANSMISSION; DNA POLYMORPHISM; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MONKEY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEQUENCE ANALYSIS; SERODIAGNOSIS; THAILAND; WOMEN'S HEALTH; ADULT; ANIMAL; BLOOD; CELL LINE; GENE FREQUENCY; GENETICS; GENOTYPE; MALE; SINGLE NUCLEOTIDE POLYMORPHISM; VIROLOGY;

ADULT; ANIMALS; CELL LINE; FEMALE; GENE FREQUENCY; GENOTYPE; HIV INFECTIONS; HIV SERONEGATIVITY; HIV SEROPOSITIVITY; HIV-1; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, CCR2; RECEPTORS, CCR5; THAILAND;

EID: 42449108277     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e318162caab     Document Type: Article

References (25)

1. Fowke KR, Nagelkerke NJ, Kimani J, et al. Resistance to HIV-1 infection among persistently seronegative prostitutes in Nairobi, Kenya. Lancet. 1996;348:1347-1351.
2. Mann JM, Quinn TC, Francis H, et al. Prevalence of HTLV-III/LAV in household contacts of patients with confirmed AIDS and controls in Kinshasa, Zaire. JAMA. 1986;256:721-724.
3. O'Brien SJ, Nelson GW. Human genes that limit AIDS. Nat Genet. 2004;36:565-574.
4. Wichukchinda N, Kitamura Y, Rojanawiwat A, et al. The polymorphisms in DC-SIGNR affect susceptibility to HIV-1 infection. AIDS Res Hum Retroviruses. 2007;23:686-692.
5. Samson M, Libert F, Doranz BJ, et al. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature. 1996;382:722-725.
6. Liu R, Paxton WA, Choe S, et al. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell. 1996;86:367-377.
7. Dean M, Carrington M, Winkler C, et al. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science. 1996;273:1856-1862.
8. Huang Y, Paxton WA, Wolinsky SM, et al. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nat Med. 1996;2:1240-1243.
9. Martinson JJ, Chapman NH, Rees DC, et al. Global distribution of the CCR5 gene 32-basepair deletion. Nat Genet. 1997;16:100-103.
10. Jiang JD, Wang Y, Wang ZZ, et al. Low frequency of the ccr5delta32 HIV-resistance allele in mainland China: identification of the first case of ccr5delta32 mutation in the Chinese population. Scand J Infect Dis. 1999;31:345-348.
11. Ruchusatsawat N, Vongsheree S, Thaisri H, et al. The first report of CCR5 delta 32 mutant in Thai injecting drug users. Asian Pac J Allergy Immunol. 2000;18:93-98.
12. Martin MP, Dean M, Smith MW, et al. Genetic acceleration of AIDS progression by a promoter variation of CCR5. Science. 1998;282:1907-1911.
13. Smith MW, Carrington M, Winkler C, et al. CCR2 chemokine receptor and AIDS progression. Nat Med. 1997;3:1052-1053.
14. Kostrikis LG, Huang Y, Moore JP, et al. A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation. Nat Med. 1998;4:350-353.
15. Mulherin SA, O'Brien TR, Ioannidis JP, et al. Effects of CCR5-Delta32 and CCR2-64I alleles on HIV-1 disease progression: the protection varies with duration of infection. AIDS. 2003;17:377-387.
16. Wichukchinda N, Nakayama EE, Rojanawiwat A, et al. Protective effects of IL4-589T and RANTES-28G on HIV-1 disease progression in infected Thai females. AIDS. 2006;20:189-196.
17. Liu H, Nakayama EE, Theodorou I, et al. Polymorphisms in CCR5 chemokine receptor gene in Japan. Int J Immunogenet. 2007;34:325-335.
18. Capoulade-Metay C, Ma L, Truong LX, et al. New CCR5 variants associated with reduced HIV coreceptor function in southeast Asia. AIDS. 2004;18:2243-2252.
19. Ma L, Dudoit Y, Tran T, et al. Biochemical and HIV-1 coreceptor properties of K26R, a new CCR5 Variant in China's Sichuan population. J Acquir Immune Defic Syndr. 2005;39:38-43.
20. Ansari-Lari MA, Liu XM, Metzker ML, et al. The extent of genetic variation in the CCR5 gene. Nat Genet. 1997;16:221-222.
21. Charo IF, Myers SJ, Herman A, et al. Molecular cloning and functional expression of two monocyte chemoattractant protein 1 receptors reveals alternative splicing of the carboxyl-terminal tails. Proc Natl Acad Sci U S A. 1994;91:2752-2756.
22. Wong LM, Myers SJ, Tsou CL, et al. Organization and differential expression of the human monocyte chemoattractant protein 1 receptor gene. Evidence for the role of the carboxyl-terminal tail in receptor trafficking. J Biol Chem. 1997;272:1038-1045.
23. Nakayama EE, Tanaka Y, Nagai Y, et al. A CCR2-V64I polymorphism affects stability of CCR2A isoform. AIDS. 2004;18:729-738.
24. Wu L, Paxton WA, Kassam N, et al. CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro. J Exp Med. 1997;185:1681-1691.
25. Shioda T, Nakayama EE, Tanaka Y, et al. Naturally occurring deletional mutation in the C-terminal cytoplasmic tail of CCR5 affects surface trafficking of CCR5. J Virol. 2001;75:3462-3468.